A simple immunofluorescence test for the detection of platelet antibodies. 1978

A E von dem Borne, and F W Verheugt, and F Oosterhof, and E von Riesz, and A B de la Rivière, and C P Engelfriet

Immunofluorescence tests on platelets have always been hampered by nonspecific fluorescence caused by non-immunological binding of plasma proteins to the platelet membrane. It was found that this could be easily overcome by fixation of the cells with paraformaldehyde (PFA). By using PFA-fixed platelets, a simple method for the detection of platelet antibodies, the platelet suspension immunofluorescence test (PSIFT) was developed. PFA fixation did not alter or inactivate the platelet antigens tested. Platelet-reactive antibodies detected specifically with the PSIFT included platelet-specific agglutinins of the IgM class, non-agglutinating platelet-specific antibodies of the IgG class, drug-dependent platelet antibodies, HLA antibodies, as well as anti-A and anti-B antibodies. The sensitivity of the new test was satisfactory, as was its reproducibility. Measurement of platelet immunofluorescence was possible in a continuous flow microfluorometer, making a principle, quantitation of platelet antibodies and antigens possible.

UI MeSH Term Description Entries
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D005557 Formaldehyde A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717) Formalin,Formol,Methanal,Oxomethane
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

A E von dem Borne, and F W Verheugt, and F Oosterhof, and E von Riesz, and A B de la Rivière, and C P Engelfriet
December 1983, American journal of clinical pathology,
A E von dem Borne, and F W Verheugt, and F Oosterhof, and E von Riesz, and A B de la Rivière, and C P Engelfriet
August 1977, Zeitschrift fur Hautkrankheiten,
A E von dem Borne, and F W Verheugt, and F Oosterhof, and E von Riesz, and A B de la Rivière, and C P Engelfriet
October 1991, Indian journal of pathology & microbiology,
A E von dem Borne, and F W Verheugt, and F Oosterhof, and E von Riesz, and A B de la Rivière, and C P Engelfriet
January 1980, Journal of immunological methods,
A E von dem Borne, and F W Verheugt, and F Oosterhof, and E von Riesz, and A B de la Rivière, and C P Engelfriet
December 1981, Blut,
A E von dem Borne, and F W Verheugt, and F Oosterhof, and E von Riesz, and A B de la Rivière, and C P Engelfriet
July 1987, British journal of haematology,
A E von dem Borne, and F W Verheugt, and F Oosterhof, and E von Riesz, and A B de la Rivière, and C P Engelfriet
November 1974, Journal of clinical pathology,
A E von dem Borne, and F W Verheugt, and F Oosterhof, and E von Riesz, and A B de la Rivière, and C P Engelfriet
April 1981, Blood,
A E von dem Borne, and F W Verheugt, and F Oosterhof, and E von Riesz, and A B de la Rivière, and C P Engelfriet
September 2014, Clinical nephrology,
A E von dem Borne, and F W Verheugt, and F Oosterhof, and E von Riesz, and A B de la Rivière, and C P Engelfriet
November 1993, Muscle & nerve,
Copied contents to your clipboard!